Effect of CDK7 inhibitor on protein expression alterations in cultured secondary AML HEL92.1.7 cells
Ontology highlight
ABSTRACT: HEL92.1.7 cells in exponential growth phase were treated with 100 nM of SY-5609 for 24 hours to determine the global protein expression alterations that correlate with the cell cycle, growth inhibitory and lethal effects of treatment with a CDK7 inhibitor in secondary AML cells.
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
SUBMITTER:
Antrix Jain
LAB HEAD: Kapil N. Bhalla
PROVIDER: PXD053572 | Pride | 2025-04-28
REPOSITORIES: Pride
ACCESS DATA